SCHEMBL5041491

SCHEMBL5041491

COC(C(=O)NCc1ccc(C#N)cc1)c1c(F)ccc(O)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.42
EPHX2 P34913 1/20 0.40
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
HIF1A Q16665 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37
ERCC1 P07992 2/20 0.36
ERCC4 Q92889 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
AKR1B1 P15121 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
PPARA Q07869 1/20 0.36
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
ALDH1A1 P00352 1/20 0.35
VNN1 O95497 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041495 1.00 PKM (0.42) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5043811 0.89 EPHX2 (0.38) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5043807 0.89 EPHX2 (0.38) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5040768 0.88 PKM (0.41) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5040771 0.88 PKM (0.41) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5038276 0.87 PKM (0.41) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5047731 0.87 PKM (0.43) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5042034 0.87 PKM (0.45) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5042039 0.87 PKM (0.45) PKMEPHX2SLC1A3SLC1A2HIF1A
SCHEMBL5041552 0.86 PKM (0.48) PKMEPHX2SLC1A3SLC1A2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885EPHX2 1557/4885SLC1A3 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.